• News
  • SAN DIEGO
  • BioTech

Royalty Pharma offers to buy Elan for about $6.5B

Royalty Pharma said Monday that it wants to buy Elan Corp. PLC for about $6.5 billion, but has yet to receive a formal response from the Irish drugmaker.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!